Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 SEK | +12.75% | +0.88% | +53.33% |
Sales 2023 | 5.68M 520K | Sales 2024 * | 23.65M 2.17M | Capitalization | 596M 54.66M |
---|---|---|---|---|---|
Net income 2023 | -178M -16.31M | Net income 2024 * | -155M -14.2M | EV / Sales 2023 | 48.9 x |
Net cash position 2023 | 111M 10.2M | Net Debt 2024 * | 25.35M 2.32M | EV / Sales 2024 * | 26.3 x |
P/E ratio 2023 |
-2.19
x | P/E ratio 2024 * |
-3.12
x | Employees | 31 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 57.48% |
Latest transcript on IRLAB Therapeutics AB
1 day | +12.75% | ||
1 week | +0.88% | ||
Current month | +0.88% | ||
1 month | -15.13% | ||
3 months | -10.85% | ||
6 months | +70.12% | ||
Current year | +53.33% |
Managers | Title | Age | Since |
---|---|---|---|
Clas Sonesson
FOU | Founder | 63 | 12-12-31 |
Chief Executive Officer | 71 | 17-05-05 | |
Nicholas Waters
FOU | Founder | 62 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Anders Vedin
BRD | Director/Board Member | 82 | 15-12-31 |
Rein Piir
BRD | Director/Board Member | 66 | 15-12-31 |
Chairman | 66 | 19-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 11.5 | +12.75% | 163,538 |
24-05-07 | 10.2 | -10.13% | 223,065 |
24-05-06 | 11.35 | +3.65% | 55,957 |
24-05-03 | 10.95 | -1.79% | 19,300 |
24-05-02 | 11.15 | -2.19% | 13,149 |
Delayed Quote Nasdaq Stockholm, May 08, 2024 at 06:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.33% | 54.71M | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+16.23% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- IRLAB A Stock